Ozanimod

DESCRIPTION

Ozanimod (RPC-1063) (RPC1063) is a specific oral S1P Receptor 1 modulator. Ozanimod has been used in trials studying the treatment of Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclerosis.

DETAILS

Cas: 1306760-87-1
Purity: 99.74%
Smiles: N(CCO)[C@@H]1C=2C(=C(C=CC2)C=3N=C(ON3)C4=CC(C#N)=C(OC(C)C)C=C4)CC1
Category: Compound
Molecular Weight: 404.46
Molecular Formula: C23H24N4O3

Lead Time: 4 - 5 weeks